DWP
IBB icon

Destiny Wealth Partners’s iShares Biotechnology ETF IBB Stock Holding History

Destiny Wealth Partners’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$667K Sell
3,580
-12,654
-78% -$2.17M 0.09% 80
2026
Q1 		$2.74M Sell
16,234
-60
-0.4% -$10.3K 0.3% 67
2025
Q4 		$2.87M Sell
16,294
-136
-0.8% -$22.1K 0.33% 62
2025
Q3 		$2.37M Sell
16,430
-59,354
-78% -$8.1M 0.29% 64
2025
Q2 		$9.59M Buy
75,784
+5,919
+8% +$727K 1.29% 26
2025
Q1 		$8.94M Buy
69,865
+4,358
+7% +$591K 1.42% 26
2024
Q4 		$8.66M Buy
65,507
+2,463
+4% +$346K 1.41% 23
2024
Q3 		$9.18M Sell
63,044
-13,556
-18% -$1.96M 1.61% 22
2024
Q2 		$10.5M Buy
76,600
+9,729
+15% +$1.3M 1.89% 15
2024
Q1 		$9.18M Buy
66,871
+1,041
+2% +$142K 1.64% 24
2023
Q4 		$8.99M Buy
65,830
+3,260
+5% +$398K 1.69% 23
2023
Q3 		$7.65M Buy
62,570
+933
+2% +$119K 1.54% 26
2023
Q2 		$8.1M Buy
61,637
+2,970
+5% +$386K 1.55% 22
2023
Q1 		$7.58M Buy
58,667
+8,488
+17% +$1.11M 1.57% 21
2022
Q4 		$6.59M Sell
50,179
-9,323
-16% -$1.2M 1.43% 24
2022
Q3 		$6.96M Buy
59,502
+1,599
+3% +$199K 1.56% 23
2022
Q2 		$6.81M Sell
57,903
-56
-0.1% -$6.65K 1.5% 24
2022
Q1 		$7.55M Buy
57,959
+41,088
+244% +$5.35M 1.47% 25
2021
Q4 		$2.58M Buy
16,871
+3,009
+22% +$466K 0.5% 53
2021
Q3 		$2.24M Sell
13,862
-2,016
-13% -$339K 0.45% 58
2021
Q2 		$2.6M Buy
15,878
+210
+1% +$32.3K 0.5% 54
2021
Q1 		$2.36M Sell
15,668
-858
-5% -$136K 0.49% 53
2020
Q4 		$2.5M Buy
+16,526
New +$2.36M 0.52% 51

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Destiny Wealth Partners's IBB Position: Q2 2026 in Review

Destiny Wealth Partners reduced its iShares Biotechnology ETF (IBB) stake by 78% in Q2 2026, selling an estimated $2.17M and leaving 3,580 shares worth $667K. The position accounts for 0.09% of the portfolio, ranked #80.

Destiny Wealth Partners first reported a position in IBB in Q4 2020 and has held it in 23 quarters since. The position peaked at $10.5M in Q2 2024. 956 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Destiny Wealth Partners held 3,580 shares of iShares Biotechnology ETF worth $667K as of Q2 2026.
  • Destiny Wealth Partners sold 12,654 iShares Biotechnology ETF shares in Q2 2026, an estimated $2.17M.
  • iShares Biotechnology ETF made up 0.09% of Destiny Wealth Partners's portfolio in Q2 2026, its #80 holding.
  • Destiny Wealth Partners first reported a position in iShares Biotechnology ETF in Q4 2020 and has held it in 23 quarters since.
  • Destiny Wealth Partners's iShares Biotechnology ETF position peaked at $10.5M in Q2 2024.
  • 956 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Destiny Wealth Partners's 13F filing for Q2 2026, filed 7 Aug 2026.